Probiotics may alleviate symptoms of hay fever, which may be related to bacteria in our gut and nose.

Published Date: 26 Apr 2023

The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.

Read Full News

Latest News

Optimizing Treatment Access and Outcomes for Patients With Eosinophilic Esophagitis: A Regional Workshop Series Aligning Payer and Clinician Approaches

Optimizing Treatment Access and Outcomes for Patients With Eosinophilic Esophagitis: A Regional Workshop Series Aligning Payer and Clinician Approaches

Trump Cuts Mask True Extent of Cyclospora Outbreaks

Source of infection still unknown in several other cyclosporiasis clusters

'Practice-Changing' Data Expand Zanidatamab's Approval to Gastroesophageal Cancer

Bispecific antibody plus chemo with or without tislelizumab improves OS, PFS versus trastuzumab

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

RAS inhibitor daraxonrasib doubled survival outcomes in second-line trial

Nonsurgical Options for Early Rectal Cancer Continue to Show Promise

60-80% of patients avoided surgery for a year or longer in trial

GI Doc Awakes to Bat in Mouth; Stopped Farting? Uh-Oh; FDA Approves GERD Implant

News and commentary from the world of gastroenterology and hepatology

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Latest News

Optimizing Treatment Access and Outcomes for Patients With Eosinophilic Esophagitis: A Regional Workshop Series Aligning Payer and Clinician Approaches

Source of infection still unknown in several other cyclosporiasis clusters

Bispecific antibody plus chemo with or without tislelizumab improves OS, PFS versus trastuzumab

RAS inhibitor daraxonrasib doubled survival outcomes in second-line trial

60-80% of patients avoided surgery for a year or longer in trial

News and commentary from the world of gastroenterology and hepatology

News All Time

The Challenge of Diagnosing Abdominal Pain and Diarrhea

Did the young woman have IBD, IBS, or infection?

Less Frequent Colonoscopy After Polyp Removal Could Be the Way to Go, Study Suggests

Findings show similar incidence of colorectal cancer with colonoscopy at 3 and 5 years

Ulcerative Colitis With an Unexpected Cause

Can the immune response to COVID-19 trigger inflammatory bowel disease?

What Is Causing This Constellation of Symptoms in a 57-Year-Old Man?

Stomach pain, wheezing, and night sweats add up to a diagnosis of a rare but increasing condition

Brain Disorder Due to Vitamin Deficiency Often Goes Unrecognized

Korsakoff syndrome was hard to diagnose and frequently led to death

Pamela Anderson's Hepatitis; Statins After Colon Cancer; Fall Vaccines in Gastro/Hep

News and commentary from the world of gastroenterology and hepatology

Study Assesses Who's at Risk for Young-Onset MASLD Cirrhosis

Younger patients appear to have a combo of genetic susceptibility and metabolic risk factors

3 Common Drugs Older Adults Might Be Overusing

— "They're easy to start, but they can be hard to stop," says one expert

Endoscopy AI Faces a Skill and Trust Reckoning

Does AI promote deskilling in gastroenterologists? How should human-AI workflows be designed in the endoscopy suite? How should clinicians calibrate and validate AI-based tools?

Nurse-Led Program Reduces Death Anxiety in Breast Cancer

A structured nurse-led support program combining in-person and virtual sessions reduces death anxiety among women with breast cancer undergoing hormonal therapy, a study reports.

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

US Health Secretary Robert F. Kennedy Jr. on Thursday named eight new members to the advisory panel that decides which preventive medical care, such as routine cancer...

Are Vaginal Probiotics Actually Doing Anything?

Clinical evidence varies by probiotic strain, formulation, dose, and treatment setting, while broad wellness claims may encourage self-diagnosis and delay appropriate care.

Americans Pop Probiotics but Skip the Fiber, Experts Warn

Probiotic supplement use increased substantially among US adults and children from 2009 to 2023; however, dietary fiber intake remained well below recommended levels.

US Declares End Of Largest Recorded Cyclosporiasis Outbreak

U.S. health authorities on Friday declared the nation's largest recorded multistate cyclosporiasis outbreak over, after contaminated iceberg lettuce sickened thousands,...

New AGA Guidance on Cancer Surveillance in Seniors

New guidance says continuing surveillance should factor in comorbidities, life expectancy, risks vs benefits, and surgical tolerance levels, as well as patient preferences.

Relapse Uncommon After Surgery for Appendiceal Cancer

But the risk of relapse after resection of localized appendiceal adenocarcinoma varies by histologic subtype, with potential implications for risk assessment and adjuvant treatment.

Recommended News For You

EMA Backs Breast Cancer SERD After FDA No Vote

Stereotactic Radiation Linked to Better Brain Mets Outcomes

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

Use of marijuana and alcohol simultaneously is associated with worse outcomes.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

Recommended Articles For You

The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy  

Integrated Trends in Hematology for Modern Medicine 

Essential Strategies in Hematology for Healthcare Excellence 

Individualized Hematopoietic Reserve Assessment in Blood Disorders 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

2.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

3.

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

4.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

5.

Dramatic Increase in Active Surveillance Use for Prostate Cancer

1.

Immune Ecosystem Remodeling Within Solid Tumor Niches

2.

Emerging Methods in Hematology in Clinical Decision-Making

3.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

4.

Nuclear Medicine's Role in Battling Women's Cancers

5.

Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Blood Clotting Disorders Explained

2.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

5.

Should We Use DARA Up Front As First-Line Therapy in MM?


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot